Detalhe da pesquisa
1.
Prostate cancer-specific mortality burden by risk group among men with localized disease: Implications for research and clinical trial priorities.
Prostate
; 80(13): 1128-1133, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32659024
2.
Receipt of definitive therapy in elderly patients with unfavorable-risk prostate cancer.
Cancer
; 123(24): 4832-4840, 2017 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28832984
3.
Active Surveillance for Low-Risk Prostate Cancer in Black Patients.
N Engl J Med
; 380(21): 2070-2072, 2019 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31116925
4.
Risk of prostate cancer mortality in men with a history of prior cancer.
BJU Int
; 117(6B): E20-8, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25845283
5.
Association between very small tumour size and increased cancer-specific mortality after radical prostatectomy in lymph node-positive prostate cancer.
BJU Int
; 118(2): 279-85, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26235660
6.
Variation in National Use of Long-Term ADT by Disease Aggressiveness Among Men With Unfavorable-Risk Prostate Cancer.
J Natl Compr Canc Netw
; 14(4): 421-8, 2016 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27059190
7.
Incidence and Predictors of Upgrading and Up Staging among 10,000 Contemporary Patients with Low Risk Prostate Cancer.
J Urol
; 194(2): 343-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25681290
8.
Impact of the COVID-19 Pandemic on Cancer Care and Quality of Life for Patients With Breast and Gynecologic Malignancies: A Single-Center Survey-Based Study.
J Patient Exp
; 9: 23743735221077543, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35187223
9.
Patient Perception of Telehealth Services for Breast and Gynecologic Oncology Care during the COVID-19 Pandemic: A Single Center Survey-based Study.
J Breast Cancer
; 23(5): 542-552, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33154829
10.
Impact of percent positive biopsy cores on cancer-specific mortality for patients with high-risk prostate cancer.
Urol Oncol
; 38(9): 735.e9-735.e15, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32654951
11.
Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate Cancer.
Eur Urol Focus
; 5(1): 69-76, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28753811
12.
Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active Surveillance.
Clin Genitourin Cancer
; 16(3): 226-234, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29196209
13.
Disparities in the Receipt of Local Treatment of Node-positive Prostate Cancer.
Clin Genitourin Cancer
; 15(5): 563-569.e3, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28462857
14.
National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys
; 98(2): 338-343, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28463152
15.
Low rates of androgen deprivation therapy use with salvage radiation therapy in patients with prostate cancer after radical prostatectomy.
Urol Oncol
; 35(9): 542.e25-542.e32, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28533151
16.
Association Between Travel Distance and Choice of Treatment for Prostate Cancer: Does Geography Reduce Patient Choice?
Int J Radiat Oncol Biol Phys
; 96(2): 313-317, 2016 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27496390
17.
Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys
; 94(4): 683-90, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26972640
18.
Association of Androgen Deprivation Therapy With Depression in Localized Prostate Cancer.
J Clin Oncol
; 34(16): 1905-12, 2016 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27069075
19.
Occult High-risk Disease in Clinically Low-risk Prostate Cancer with ≥50% Positive Biopsy Cores: Should National Guidelines Stop Calling Them Low Risk?
Urology
; 87: 125-32, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26391387
20.
Significant increase in prostatectomy and decrease in radiation for clinical T3 prostate cancer from 1998 to 2012.
Urol Oncol
; 34(2): 57.e15-22, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26476663